Embed Size (px)
Citation preview
PROGRAM _MARCH 14 (Thu.), 2019
VISTA 1 VISTA 2 VISTA 3 GRAND HALL
08:00-09:00 REGISTRATION
09:00-10:30
[JS01]
KAI-KSH JOINT
SESSION
[SS01]
BONE MARROW
FAILURE
IMMUNOTHERAPEUTICS IN BLOOD DISEASE
Immune checkpoint inhibitor in cancer
(Seung-Woo lee, Korea)
Towards next-generation CAR-T cell therapy for
cancer(Chan Hyuk Kim, Korea)
Cytotoxic T lymphocyte therapy
(Hyewon Lee, Korea)
Immune checkpoint inhibitor in lymphoma
(Yoon Seok Choi, Korea)
Paroxysmal nocturnal hemoglobinuria in bone
marrow failure(Jun Ho Jang, Korea)
Germline mutations in inherited BM failure
(Jean Soulier, France)
Telomere length and somatic mutations in
aplastic anaemia(Dong Soon Lee, Korea)
10:30-10:45 Coffee Break
10:45-11:45
PLENARY LECTURE I
GENE THERAPY IN HEMATOLOGY
Application of CRISPR/Cas-9 in blood disease(Matthew H.Porteus, USA)
Gene therapy for hemophilia(Katherine High, USA)
11:45-12:45
PRESIDENTIAL SYMPOSIUM
Stem cells in human AML(Ravindra Majeti, USA)
Optimal treatment of adolescents and young adult ALL(Ching-Hon Pui, USA)
12:45-13:40
[LS01]
LUNCHEON
SYMPOSIUM
[LS02]
LUNCHEON
SYMPOSIUM
[LS03]
LUNCHEON
SYMPOSIUM
PROGRAM _MARCH 14 (Thu.), 2019
13:40-14:40
[AS01]
ASIAN HEMATOLOGY
SYMPOSIUM
[AS02]
ASIAN HEMATOLOGY
SYMPOSIUM
VISTA 1 VISTA 2 VISTA 3 GRAND HALL
14:55-16:25
[JS02]
KOGO-KSH JOINT
SESSION
[SS02]
MULTIPLE MYELOMA
[SS03]
TRANSPLANTATION/
CELL THERAPY
[ES01]
IRON METABOLISM
GENOMICS FOR PRECISION
HEMATOLOGY
Understanding angioimmunoblastic T-cell lymphoma: from genomics
to animal pathology(Jaesang Kim, Korea)
Genomic pathogenesis of epstein–barr virus (EBV) -
induced diffuse large B cell lymphoma
(Sung-Yup Cho, Korea)
Current status of precision hematology
(Young-Uk Cho Korea)
Clinical application of precision hematology
(Joon-Ho Moon, Korea)
Strategy to overcome treatment resistance in
high risk multiple myeloma(Lugui Qiu, China)
What role does bone marrow microenvironment
play on MM cells(Yusuke Furukawa, Japan)
Antigen-mediated regulation in MM
(Madhav Dhodapkar, USA)
TK cell therapy(Maria Chiara Bonini, Italy)
Updates on CAR T cell therapy for multiple
myeloma(Jesús Berdeja, USA)
New insights into cancer vaccine strategies(Larry Kwak, USA)
Iron metabolism in hemoglobinopathies
(Vip Viprakasit, Thailand)
Deferasirox for iron overload patients:
preserving organ functions (Norbert Gattermann,
Germany)
Managing side effects in iron chelation therapy
(Heather Leitch, Canada)
16:25-16:40 Break
16:40-18:10
[SS04]
MYELOPROLIFERATIVE
NEOPLASM
[SS05]
BLEEDING DISORDER/
THROMBOSIS
[SS06]
PEDIATRIC DISEASE
[ES02]
INDOLENT
LYMPHOMA
Clinical signifi cance of genetic stratifi cation of
MPN patients(Robert Kralovics, Austria)
Molecular mechanism of MPN development by
mutant calreticulin(Norio Komatsu, Japan)
Interferon treatment for MPN
(Jean-Jacques Kiladjian, France)
Progress in gene therapy for hemophilia A and B(Glenn F. Pierce, USA)
Individualized treatment for hemophilia : population
pharmacokinetics approach
(Cindy Yeung, Canada)
Mechanisms of cancer-associated thrombosis(Nigel Mackman, USA)
Inherited hematologic malignancies
(Lucy Godley, USA)
GATA2 leukemogenesis (Jean Donadieu, France)
Roles of monosomy 7 and SAMD9/SAMD9L
mutationsin myeloid leukemogenesis
(Hirotaka Matsui, Japan)
Mantle cell lymphoma -from the clinic to
genetics(Mats Jerkeman, Sweden)
From genetics to the clinic: Follicular lymphoma(Gilles Salles, France)
From genetics to the clinic of chronic lymphocytic
leukemia(Wei Xu, China)
18:30-20:00 WELCOME RECEPTION
* SESSION CODE[JS] Joint Symposium[SS] Scientifi c Session[ES] Educational Session[AS] Asian Hematology Symposium[LS] Luncheon Symposium
PROGRAM _MARCH 15 (Fri.), 2019
VISTA 1 VISTA 2 VISTA 3 GRAND HALL
08:00-09:00 REGISTRATION
09:00-10:30
[JS03]
EHA-KSH JOINT
SYMPOSIUM I
[SS07]
BENIGN
HEMATOLOGY
[SS08]
HISTIOCYTOSIS
[ES03]
ACUTE
LYMPHOBLASTIC
LEUKEMIA
MULTIPLE MYELOMA
Monoclonal antibody for MM
(TBD)
Double refractory MM(Chang-Ki Min, Korea)
Experimental therapy except monoclonal Ab (Francesca Gay, Italy)
Treatment of high risk R/R MM
(Jin Seok Kim, Korea)
Introduction of eurobloodnet and its
activity(Maria del Mar Manu,
Spain)
Clinical utility of high-throughput sequencing forthe diagnosis of hereditary
hemolytic anemia (Myungshin Kim, Korea)
Molecular spectrum of Thalassemia/
hemoglobinopathy(Cornelis Harteveld, The
Netherlands)
Recent progress in the pathogenesis and
treatment of LCH(Carl E. Allen, USA)
Treatment of HLH - today and tomorrow
(Jan-Inge Henter, Sweden)
Genetic studies on the HLH in Korea
(Jong Jin Seo, Korea)
Pharmacogenetics in patients with childhood
acute lymphoblastic leukemia
(Yoichi Tanaka, Japan)
Recent advances in the treatment of adult ALL(Won-Sik Lee, Korea)
Mutational landscape of ALL: next-generation
sequencing-based mutations scanning
strategy(Seung-Tae Lee, Korea)
10:30-10:45 Coffee Break
10:45-11:45
PLENARY LECTURE II
CLINICAL HEMATOLOGY LECTURE
Breakthroughs in the treatment of aplastic anemia(Neal Young, USA)
11:45-12:45
[AS03]
ASIAN HEMATOLOGY
SYMPOSIUM II
POSTER PRESENTATION
12:45-13:40
[LS04]
LUNCHEON
SYMPOSIUM
[LS05]
LUNCHEON
SYMPOSIUM
[LS06]
LUNCHEON
SYMPOSIUM
13:40-13:50 Coffee Break
13:50-15:05 ORAL I
15:05-16:20 ORAL II
16:20-16:35 Break
PROGRAM _MARCH 15 (Fri.), 2019
VISTA 1 VISTA 2 VISTA 3 GRAND HALL
16:35-18:05
[SS09]
FUTURE
INFORMATION AND
COMMUNICATIONS
TECHNOLOGIES
(ICT) BASED MEDICINE
[SS10]
ACUTE MYELOID
LEUKEMIA/
MYELODYSPLASTIC
SYNDROMES
[SS11]
CHRONIC MYELOID
LEUKEMIA
[ES04]
COAGULATION
Deep learning for CRISPR-Cpf1 research
(Sungroh Yoon, Korea)
Precision dinner: Genomes and health records
(Ju Han Kim, Korea)
IoT (Jack Ahn, Korea)
Genomics of core-binding factor AML
(Nicolas Duployez, France)
Precision medicine in AML in the era of novel agents
(Gail Roboz, USA)
MDS: Integrating biomarker into prognostic
models (Amer Zeidan, USA)
Is CML a single hit disorder?
(Dennis Kim, Canada)
NGS based ABL1 kinase domain mutation detection
(Simona Soverini, Italy)
Precision medicine and immunity in CML
(Satu Mustjoki, Finland)
Global hemostasis test guided management of
hemorrhage and coagulopathy
(Marc Maegele, Germany)
Clinical application of clot waveform analysis
in hemophilia treatment(Keiji Nogami , Japan)
Thrombin generation assay (Bas de Laat, The
Netherlands)
18:30-20:00 GALA DINNER
* SESSION CODE[JS] Joint Symposium[SS] Scientifi c Session[ES] Educational Session[AS] Asian Hematology Symposium[LS] Luncheon Symposium
PROGRAM _MARCH 16 (Sat.), 2019
VISTA 1 VISTA 2 VISTA 3 GRAND HALL
07:20-08:20 BUSINESS MEETING
08:20-08:30 AWARD CEREMONY
08:30-09:00WORKING PARTY
REPORTS
09:00-10:30
[JS04]
EHA-KSH JOINT
SYMPOSIUM II
[SS12]
CHILDHOOD ACUTE
LYMPHOBLASTIC
LEUKEMIA
[SS13]
LYMPHOMA
[SS14]
ADVANCES IN
TECHNOLOGY
CHRONIC MYELOID LEUKEMIA
Real-world experiences of TFR in Europe
(Jane Apperley, UK)
Treatment-free remission in CML
(Hawk Kim, Korea)
TKI-related cardiovascular toxicities in Europe (Susanne Saußele,
Germany)
Management of TKI-related toxicities
(Jee Hyun Kong, Korea)
Treatment of childhood ALL With IKZF1 deletion
(Allen Yeoh Eng Juh, Singapore)
Outcome of children with newly diagnosed
ALL treated with CCLG-ALL 2008
(Chi-kong Li, Hong Kong)
Recent updates of prospective trials in Japan
(Yasuhiro Okamoto, Japan)
Pathogenesis of EBV-associated
lymphoproliferative disorders
(Hiroshi Kimura, Japan)
Molecular understanding of peripheral T-cell
lymphoma(Iqbal Javeed, USA)
Clinical application of cell-free DNA in lymphoma(Seok Jin Kim, Korea)
Droplet Microfl uidics in antibody discovery,
immunerepertoiresequencing
and personalized cancer therapy
(Christoph Merten, Germany)
Applications of single-cell mass cytometryin hematologic malignancies
(Gregory Behbehani, USA)
Prediction of acute myeloid leukemia risk
in healthy individuals(Liran Shlush, Israel)
10:30-10:45 Coffee Break
10:45-11:45
PLENARY LECTURE III
GENOMICS IN LYMPHOID MALIGNANCIES
Genomics in ALL(Charles Mullighan, USA)
Genomics in MM (Genomics in multiple myeloma)(Gareth Morgan, USA)
11:45-12:30 AWARD CEREMONY & CLOSING
* SESSION CODE[JS] Joint Symposium[SS] Scientifi c Session[ES] Educational Session[AS] Asian Hematology Symposium[LS] Luncheon Symposium
